Clinical trials
Active, not recruiting Phase 3 trials in Vietnam
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
59 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 2 |
| 2017 | 4 |
| 2018 | 6 |
| 2019 | 3 |
| 2020 | 6 |
| 2021 | 4 |
| 2022 | 11 |
| 2023 | 11 |
| 2024 | 7 |
| 2025 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 59 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 37 |
| Novartis Pharmaceuticals | 8 |
| Merck Sharp & Dohme LLC | 4 |
| Actelion | 2 |
| Acerta Pharma BV | 1 |
| Amgen | 1 |
| Atea Pharmaceuticals, Inc. | 1 |
| Janssen Research & Development, LLC | 1 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 1 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 14 |
| Carcinoma | 5 |
| Carcinoma, Hepatocellular | 3 |
| Liver Neoplasms | 3 |
| Urinary Bladder Neoplasms | 3 |
| Acquired Immunodeficiency Syndrome | 2 |
| Breast Neoplasms | 2 |
| Cardiovascular Diseases | 2 |
| Lung Neoplasms | 2 |
| Lupus Erythematosus, Systemic | 2 |
Trials
Showing 1 to 25 of 59. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.